US · Healthcare

ProPhase Labs Inc (PRPH)

Diagnostics & Research

ProPhase Labs Inc (PRPH) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PRPH

P/E ratio

18.00

ProPhase Labs Inc (PRPH) — FAQ

What is PRPH's P/E ratio?

The price-to-earnings (P/E) ratio for ProPhase Labs Inc (PRPH) is 18.00 (data as of 2026-05-23).

Does ProPhase Labs Inc pay a dividend?

Dividend yield is not available in the current snapshot for ProPhase Labs Inc (PRPH). Check the MyAverix Finance app for the latest dividend data.

What sector is ProPhase Labs Inc in?

ProPhase Labs Inc (PRPH) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is PRPH listed on?

PRPH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)